Med. praxi. 2022;19(3):169-172 | DOI: 10.36290/med.2022.026

Early symptoms and diagnosis of multiple sclerosis by the general practitioner

MUDr. Radek Ampapa
Centrum demyelinizačních onemocnění při neurologickém oddělení Nemocnice Jihlava, p. o.

Multiple sclerosis is a chronic disease of the central nervous system. The underlying pathophysiology of the disease is an autoimmune inflammation with concomitant neurodegeneration. The clinical manifestations of nervous tissue injury are a variety of neurological symptoms that can regress spontaneously in the early stage of the disease and can be mistaken for another disease. Most frequently, they include optic nerve inflammation, impaired sensitivity, vertigo, movement disorders, diplopia, or sphincter dysfunction. An initial symptom of multiple sclerosis often prompts the patient to visit the general practitioner. Given the nature of the disease that can result in a permanent neurological deficit and the current treatment options, the role of the general practitioner in the diagnostic algorithm for multiple sclerosis is irreplaceable. Reaching the correct diagnosis promptly is essential for early initiation of treatment, significantly improving the prognosis of the disease.

Keywords: multiple sclerosis, early symptoms, diagnostic criteria.

Published: June 16, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ampapa R. Early symptoms and diagnosis of multiple sclerosis by the general practitioner. Med. praxi. 2022;19(3):169-172. doi: 10.36290/med.2022.026.
Download citation

References

  1. Thompson AJ, Baranzini SE, Geurts J, et al. Multiple sclerosis. Lancet. 2018 Apr 21;391(10130):1622-1636. Go to original source... Go to PubMed...
  2. Bjornevik K, Cortese M, Healy BC, et al. Longitudinal analysis reveals high prevalence of Epstein­‑Barr virus associated with multiple sclerosis. Science. 2022 Jan 21;375(6578):296-301. doi: 10.1126/science.abj8222. Epub 2022 Jan 13. PMID: 35025605. Go to original source... Go to PubMed...
  3. Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl J Med. 2000 Sep 28;343(13):938-52. Go to original source... Go to PubMed...
  4. Browne P, Chandraratna D, Angood C, et al. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity. Neurology. 2014 Sep 9;83(11):1022-4. Go to original source... Go to PubMed...
  5. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018 Feb;17(2):162-173. Go to original source... Go to PubMed...
  6. NF Impuls: MS centra, centra pro léčbu a diagnostiku roztroušené sklerózy. Available from: http://www. nfimpuls.cz/index.php/roztrousena­‑skleroza/ms­‑centra­‑pro­‑lecbu­‑roztrousene­‑sklerozy.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.